The Impact of Glycemic Index and Insulin Resistance
Hyperinsulinemia and impaired glucose metabolism directly impair reproductive biology. Elevated dietary glycemic index (GI), glycemic load (GL), and dietary inflammatory index (DII) are significantly associated with increased odds of infertility, ranging from OR 2.0 to 3.68 in reproductive-aged women. In women with polycystic ovary syndrome (PCOS) and anovulation, a low-glycemic index diet has been shown to increase the percentage of ovulatory cycles from 7.4% to 24.6% compared to a normal-GI diet.
Furthermore, systemic metabolic dysfunction—defined as diabetes or insulin resistance with a HOMA-IR >= 2.5—substantially reduces fecundability, displaying a fecundability odds ratio of 0.35 in men and marked suppression in overweight and obese women. These findings indicate that postprandial glycemic spikes and sustained hyperinsulinemia act as central drivers of endocrine disruption.
The Interplay of Adipose Tissue and Immune Activation
Systemic low-grade chronic inflammation, marked by immune cell infiltration and elevated circulating levels of IL-6 and TNF-alpha, interacts bidirectionally with insulin resistance and obesity. This inflammatory milieu compromises both oocyte quality and endometrial receptivity. Furthermore, body composition parameters independent of raw body mass index carry high predictive value; an increase of 0.1 units in waist-to-hip ratio is associated with a 30% reduction in the probability of conception per cycle (hazard ratio 0.706, 95% CI 0.562-0.887) in women undergoing donor insemination.
Lifestyle interventions that target adiposity and reduce systemic inflammation demonstrate powerful clinical efficacy. In overweight and obese infertile women, structured lifestyle programs increase ovulatory incidence by over 11 times, underscoring the reversibility of metabolic-driven reproductive arrest.